EWTX Positive Sentiment Score: 70/100
Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that Kevin Koch, Ph.D., President...
Tuesday, January 6, 2026 1 min read
Key Takeaway: Edgewise Therapeutics, Inc. announced that its President and CEO, Kevin Koch, Ph.D., will present at the 44th Annual J.P. Morgan Healthcare Conference scheduled for January 13, 2026. The presentation will be webcast live, providing an opportunity for interested parties to engage with the company's updates. This conference is a significant event in the healthcare sector, where Edgewise Therapeutics aims to showcase its advancements in muscle disease therapies.
Full Press Release Details
BOULDER, Colo. , Jan. 6, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX ), a leading muscle disease biopharmaceutical company, today announced that Kevin Koch, Ph.D., President and Chief Executive Officer, will present at the 44 th Annual J.P. Morgan Healthcare Conference.
Date : Tuesday, January 13, 2026
Time: 8:15 am PT (11:15 am ET)
The presentation will be webcast live; a link for the webcast can be found on the Edgewise Events & Presentations page and will be accessible for replay, for a limited time, following the conference. It is recommended that users connect to the live webcast several minutes prior to the start to ensure a timely connection.
About Edgewise Therapeutics
SOURCE Edgewise Therapeutics
21 %